Гриберо

Гриберо (Dabigatran Etexilate) is an oral anticoagulant used to reduce blood clot risk. It belongs to the direct thrombin inhibitor class, helping prevent strokes and systemic embolism. This medication is prescribed for conditions requiring blood thinning. Always consult a healthcare provider for personalized guidance.

Dabigatran Etexilate is primarily used to prevent blood clots in patients with atrial fibrillation, a condition that increases stroke risk. It is also prescribed after hip or knee replacement surgery to reduce clot formation. The medication works by blocking thrombin, a key enzyme in blood clotting. It is not suitable for everyone, so medical evaluation is essential before use.

Common effects of Dabigatran Etexilate include mild stomach discomfort, nausea, or heartburn. Some users may experience bruising more easily or minor bleeding, such as nosebleeds. These effects are generally temporary and vary by individual. Monitoring by a healthcare provider helps ensure safe and effective use.

Store Dabigatran Etexilate in its original packaging to protect from moisture. Keep it at room temperature, away from direct light and heat. Do not remove capsules from the blister pack until ready to take. Always follow the prescribed schedule and report any unusual bleeding or bruising to a doctor promptly.

Dabigatran Etexilate may interact with other blood thinners, certain antibiotics, or antifungal medications. Avoid combining it with nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, as this can increase bleeding risk. Alcohol and grapefruit products may also affect its action. Always inform your healthcare provider about all medications you take.